Invention Grant
US09127033B2 5′ modified nucleosides and oligomeric compounds prepared therefrom
有权
5'修饰的核苷和由其制备的低聚化合物
- Patent Title: 5′ modified nucleosides and oligomeric compounds prepared therefrom
- Patent Title (中): 5'修饰的核苷和由其制备的低聚化合物
-
Application No.: US13642809Application Date: 2011-04-26
-
Publication No.: US09127033B2Publication Date: 2015-09-08
- Inventor: Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- Applicant: Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McNeill Baur PLLC
- International Application: PCT/US2011/033961 WO 20110426
- International Announcement: WO2011/139699 WO 20111110
- Main IPC: C07H19/04
- IPC: C07H19/04 ; C07H19/20 ; C07H21/02 ; C07H21/04 ; C07H19/10 ; C07H19/067 ; C07H21/00

Abstract:
The present invention provides 5′ modified nucleosides and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides having at least one 5′-substituent and an optional 2′ substituent, oligomeric compounds comprising at least one of these modified nucleosides and methods of using the oligomeric compounds. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.
Public/Granted literature
- US20130116420A1 5' MODIFIED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM Public/Granted day:2013-05-09
Information query
IPC分类: